Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors – subscription rate in TO 2 of 98%
(“Moberg Pharma” or the “Company”) announces that 17,776,856 warrants of series 2023:1 (“TO 2”) were exercised for subscription of in total 17,776,856 ordinary shares for approximately SEK 320 million, corresponding to a subscription rate of approximately 98%. As announced by the Company on June 11[th], 2024, subscription and top guarantee commitments had been made for TO 2, free of charge, with certain external professional investors, and today the board of directors has resolved on a directed issue of 863,333 ordinary shares amounting to approximately SEK 16 million to the top guarantors to